BIOGENICS INC.

关于韩国 BIOGENICS INC. 的企业介绍以及其企业类型的说明

---

中文版介绍:

公司名称: (주)바이오제닉스 (BIOGENICS INC.)

公司简介:

(주)바이오제닉스是一家总部位于韩国的生物技术公司。该公司专注于利用微生物技术，特别是益生菌（Probiotics）及其代谢产物（有时称为后生元/热灭活益生菌 - Postbiotics/Paraprobiotics），进行研究、开发和生产。

核心业务:

1. 益生菌及功能性原料开发: 研究和筛选具有特定健康益处的益生菌菌株，并开发创新的功能性食品、保健食品、化妆品以及可能的药品原料。

2. 生产与制造: 利用先进的发酵和生物处理技术（如培养、浓缩、冷冻干燥、微胶囊包覆等）大规模生产高品质、高稳定性的益生菌粉末或相关成分。

3. 技术解决方案: 可能提供与益生菌应用相关的技术支持或定制化解决方案给其他企业。

企业类型:

(주)바이오제닉스 是一家 制造商 (Manufacturer) / 生产商。

该公司拥有自己的研究开发能力和生产设施（工厂）。他们不仅仅是购买和销售产品的贸易商，而是基于自身的科研实力和生产技术，直接创造和生产产品的企业。他们通常拥有核心的菌株专利、独特的生产工艺（如提高益生菌存活率和稳定性的包埋技术等）以及符合相关行业标准的生产认证（如GMP, HACCP, ISO等）。

总结:

(주)바이오제닉스是一家以研发为驱动，拥有自主生产能力的韩国生物科技制造商，专注于提供高质量的益生菌及其衍生功能性原料。

---

English Translation:

Company Introduction:

BIOGENICS INC. is a biotechnology company headquartered in South Korea. The company specializes in the research, development, and production utilizing microbial technology, particularly focusing on probiotics and their metabolites (sometimes referred to as postbiotics or paraprobiotics).

Core Business Areas:

1. Development of Probiotics and Functional Ingredients: Researching and screening probiotic strains with specific health benefits, and developing innovative ingredients for functional foods, health supplements, cosmetics, and potentially pharmaceutical applications.

2. Production and Manufacturing: Utilizing advanced fermentation and bioprocessing technologies (such as cultivation, concentration, freeze-drying, microencapsulation, etc.) to mass-produce high-quality, stable probiotic powders or related ingredients.

3. Technological Solutions: Potentially offering technical support or customized solutions related to probiotic applications to other businesses.

Company Type:

BIOGENICS INC. is a Manufacturer / Producer.

The company possesses its own research and development (R&D) capabilities and production facilities (factories). They are not merely a trading company that buys and sells products; rather, they are an enterprise that directly creates and manufactures products based on their own scientific expertise and production technology. They typically hold core strain patents, unique manufacturing processes (such as coating technologies to enhance probiotic viability and stability), and possess production certifications compliant with relevant industry standards (e.g., GMP, HACCP, ISO).

Summary:

BIOGENICS INC. is an R&D-driven South Korean biotechnology manufacturer with independent production capabilities, focused on providing high-quality probiotics and their derived functional ingredients.

here are the products manufactured or sold by BIOGENICS INC. in South Korea, presented in English, based on information typically found on their official website and public sources:

BIOGENICS INC. (South Korea) primarily focuses on the research, development, and production of Postbiotics and related functional ingredients derived from microorganisms, especially lactic acid bacteria.

Their main product categories include:

1. Postbiotic Ingredients:

These are their core offerings, often based on heat-treated (heat-killed) lactic acid bacteria or their metabolites.

A key example is their ingredient derived from heat-killed Lactobacillus plantarum (often marketed under specific trademarks like nF1).

2. Functional Food Ingredients:

Ingredients intended for use in health functional foods, dietary supplements, and general food products, leveraging their postbiotic technology for various health benefits (e.g., gut health, immune support).

3. Cosmetic Ingredients:

Bio-active ingredients developed using their fermentation technology and microbial resources for use in skincare and cosmetic products, often focusing on skin barrier function, moisturizing, or soothing effects.

4. (Potentially) Animal Feed Additives:

While primarily focused on human applications, they may also offer ingredients based on similar technologies for the animal feed industry to promote livestock or pet health.

Essentially, they specialize in creating value-added ingredients from microbial sources, with a strong emphasis on the postbiotics market segment.

Disclaimer: This information is based on publicly available data, primarily the company's website (biogenics.co.kr). For the most current and exhaustive product list, contacting the company directly or checking their latest official materials is recommended.